0.60
-0.004(-0.66%)
Currency In USD
| Previous Close | 0.6 |
| Open | 0.6 |
| Day High | 0.64 |
| Day Low | 0.42 |
| 52-Week High | 19.9 |
| 52-Week Low | 0.26 |
| Volume | 56,772 |
| Average Volume | 130,858 |
| Market Cap | 2.71M |
| PE | 1.67 |
| EPS | 0.36 |
| Moving Average 50 Days | 2.63 |
| Moving Average 200 Days | 6.01 |
| Change | -0 |
If you invested $1000 in Biora Therapeutics, Inc. (BIOR) since IPO date, it would be worth $1.83 as of December 22, 2024 at a share price of $0.6. Whereas If you bought $1000 worth of Biora Therapeutics, Inc. (BIOR) shares 3 years ago, it would be worth $10.71 as of December 22, 2024 at a share price of $0.6.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
GlobeNewswire Inc.
Nov 07, 2024 9:30 PM GMT
SAN DIEGO, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced it will report financial results and provide a corporate update for the third quarter ended
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire Inc.
Oct 29, 2024 12:00 PM GMT
SAN DIEGO, Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today announced that it has entered into definitive agreements for the purchase and sale of 745,342 shares o
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
GlobeNewswire Inc.
Oct 28, 2024 12:00 PM GMT
Expanded collaborations to support rapid testing in advanced animal models in Q4 2024SAN DIEGO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company reimagining therapeutic delivery, today is sharing progre